Stage of Development: Phase 3
Team: Tarek Loubani, Chelsea Darling, Bilal Bagda,
The electrocardiogram records the electrical activity of the heart and thus a fundamental diagnostic tool. Despite recent advances in bringing more affordable ECGs to market, there still exists a shortage in low-resource settings not met by the devices currently available. The Glia model aims to address this need as a low-cost high-quality option.
The prototype of the ECG has been completed and will soon begin Health Canada approved phase 1 clinical trials. These trials seek to validate the device and compare it to the gold standard 12-lead ECG device (MAC 5500 HD Resting ECG System, GE Medical Systems) used in the standard of care at LHSC emergency departments.
For more information, stay tuned on our ECG MM!